For the analyses of target gene expression in the CaCo-2 cells with quantitative RT–PCR, total RNA was isolated (Sigma), reverse transcription was performed with added DNAse treatment, and qPCR analyses were performed

as described above for biopsy samples. Markers of apoptosis were bcl-2 (Hs00608023_m1) and BAX (Hs00180269_m1). Ribosomal 18 s RNA was used as an endogenous control (Hs99999901_s1). The data analysis was performed with SPAW statistics version 17·0 for Windows (SPSS Inc., Chigaco, IL, USA) and GraphPad prism software (San Diego, CA, USA). For comparisons between the groups, the non-parametric Kruskal–Wallis test and Mann–Whitney U-test were used. The Spearman’s rank correlation test was applied to analyse correlations between different parameters. P-values < 0·05 were considered significant. The Ethics Trametinib nmr Committee of the Hospital for Children and Adolescents, Helsinki University Central Hospital, Finland and the Regional Ethics Committee for Human Research at the University Hospital of Linköping, Sweden approved the study plans and written informed consent was obtained from parents and children. The results of the immunohistochemistry and qPCR analyses of the small intestinal biopsies from the Finnish study population consisting of children with untreated CD, children with T1D and reference children are shown in Fig. 1. The expression of IL-17-positive cells and IL-17-specific

mRNA levels differed significantly between the groups (P = 0·029 and P < 0·001, respectively, Kruskal–Wallis test). The density of intestinal IL-17-positive cells was Tacrolimus (FK506) increased in untreated CD https://www.selleckchem.com/products/Erlotinib-Hydrochloride.html compared to the T1D patients (P = 0·039, Mann–Whitney U-test) (Fig. 1a). Additionally, the IL-17 mRNA level was higher in untreated CD than in subjects with T1D or reference children (P < 0·001 for both comparisons, Mann–Whitney U-test) (Fig. 1b). In T1D, no difference in the number of IL-17-positive cells or transcripts was seen in comparison to the reference children. In children with untreated CD the expression of IL-17-positive cells correlated positively with the IL-17 mRNA

expression levels (R = 0·444; P = 0·111, Spearman), whereas no such correlation was seen in the reference group (R = −0·247; P = 0·555, Spearman) or in children with T1D (R = −0·104; P = 0·775, Spearman). The number of FoxP3-positive cells and FoxP3-specific mRNA differed significantly between the groups (P = 0·003 and P = 0·008, respectively, Kruskal–Wallis test) (Fig. 1c,d). Increased numbers of FoxP3-positive cells were found in untreated CD when compared to T1D and reference children (P = 0·003 and P = 0·006, respectively, Mann–Whitney U-test) (Fig. 1c). Additionally, untreated CD had higher FoxP3 mRNA levels than subjects with T1D and reference children (P = 0·007 and P = 0·015, respectively, Mann–Whitney U-test) (Fig. 1d).